Myocardial Reperfusion Injury Clinical Trial
Official title:
Delayed Angioplasty Postconditioning in STEMI Patients
The investigators previously reported that angioplasty postconditioning reduces infarct size
(cardiac enzyme release) in STEMI patients with a fully occluded coronary artery at hospital
admission. Animal studies have suggested that the time window for applying brief episodes of
ischemia and reperfusion aimed at triggering postconditioning's protection is very narrow,
i.e. does not expand beyond 1 minute after reflow. We sought to address whether this window
might be larger in humans, i.e. whether STEMI patients might be protected several minutes
after undergoing spontaneous reperfusion before admission coronary angiography.
Therefore, STEMI patients (onset of chest pain less than 12 hours) with a TIMI flow grade >
1 were eligible for that study. Angioplasty postconditioning was completed as already
published and infarct size was assessed by measuring cardiac enzymes release.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT00989508 -
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04570514 -
Optimized Cardioprotection Therapy in Obese Subjects With AMI
|
||
| Active, not recruiting |
NCT01857414 -
Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI
|
N/A | |
| Completed |
NCT02342522 -
Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI)
|
N/A | |
| Active, not recruiting |
NCT05462730 -
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
|
Phase 2 | |
| Completed |
NCT04397939 -
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
|
||
| Withdrawn |
NCT02098629 -
Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction
|
Phase 1/Phase 2 | |
| Completed |
NCT00586820 -
Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
|
Phase 2 | |
| Completed |
NCT02390674 -
Ciclosporin to Reduce Reperfusion Injury in Primary PCI
|
Phase 2 | |
| Completed |
NCT00865722 -
Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01307371 -
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)
|
Phase 1 | |
| Completed |
NCT01379261 -
Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction
|
Phase 2/Phase 3 | |
| Completed |
NCT00881686 -
Myocardial Protection With Adenosine Preconditioning
|
Phase 1/Phase 2 | |
| Completed |
NCT00484575 -
Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03995732 -
Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury
|
Phase 2 | |
| Recruiting |
NCT05775380 -
The Role of Pioglitazone in Vascular Transcriptional Remodeling
|
Phase 4 | |
| Completed |
NCT05354648 -
Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients
|
N/A | |
| Completed |
NCT01601795 -
Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)
|
Phase 4 | |
| Completed |
NCT01354808 -
ACCEL-LOADING-ACS Study
|
Phase 4 | |
| Withdrawn |
NCT02866630 -
Coronary Sinus Blood Sevoflurane and Desflurane Concentration and Lactate Changes in Patients Undergoing Heart Surgery
|
N/A |